Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria
暂无分享,去创建一个
[1] L. Irwig,et al. Screening for Type 2 diabetes mellitus: a decision analytic approach , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[2] M. Engelgau,et al. Screening for NIDDM in Nonpregnant Adults: A review of principles, screening tests, and recommendations , 1995, Diabetes Care.
[3] N. Wareham,et al. Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice , 2000, Diabetes/metabolism research and reviews.
[4] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[5] R. Hamman. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). , 1992, Diabetes/metabolism reviews.
[6] O. Pedersen,et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study , 1999, The Lancet.
[7] M. Harris,et al. Undiagnosed NIDDM: Clinical and Public Health Issues , 1993, Diabetes Care.
[8] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[9] C. Shaw,et al. Psychological impact of predicting individuals' risks of illness: a systematic review. , 1999, Social science & medicine.
[10] C. Palmer,et al. Undiagnosed Glucose Intolerance in the Community: the Isle of Ely Diabetes Project , 1995, Diabetic medicine : a journal of the British Diabetic Association.
[11] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[12] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[13] UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. , 1990, Diabetes research.
[14] E. Feskens,et al. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.
[15] Bruce H. R. Wolffenbuttel,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.
[16] S. Yusuf,et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.
[17] S. Yusuf,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[18] L. Bouter,et al. Performance of an NIDDM Screening Questionnaire Based on Symptoms and Risk Factors , 1997, Diabetes Care.
[19] J. Richardson,et al. Cost-Effectiveness of the Primary Prevention of Non-Insulin Dependent Diabetes Mellitus , 1997 .
[20] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[21] R. Klein,et al. Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.
[22] S. Haffner,et al. Evidence of bimodality of two hour plasma glucose concentrations in Mexican Americans: results from the San Antonio Heart study. , 1985, Journal of chronic diseases.
[23] S. Yusuf,et al. Dysglycaemia and risk of cardiovascular disease , 1996, The Lancet.
[24] R. Hanson,et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes , 1994, BMJ.
[25] B. Howard,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.